Use of Bevacizumab in the Management of Potentially Resectable Colorectal Liver Metastases: Safety, Pathologic Assessment and Benefit
Crossref DOI link: https://doi.org/10.1007/s11888-016-0326-5
Published Online: 2016-06-04
Published Print: 2016-08
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Innominato, Pasquale F.
Adam, René
License valid from 2016-06-04